FDA Warning: Hidden Dangers of Smuggled Tirzepatide in Peptide Markets The FDA has issued a warning about the risks of smuggled tirzepatide as the peptide therapeutics market grows rapidly. The market is expected to jump from $38 billion in 2023 to $106 billion by 2033, with an Eli lilly GLP1 peptides impressive 10.8% compound annual growth rate.